Janney Montgomery Scott
IMRX icon

Janney Montgomery Scott’s Immuneering IMRX Stock Holding History

Janney Montgomery Scott’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,055
Closed -$46K – 2712
2024
Q1 		$46K Sell
16,055
-4,095
-20% -$22.9K ﹤0.01% 2685
2023
Q4 		$148K Sell
20,150
-1,985
-9% -$13.2K ﹤0.01% 2516
2023
Q3 		$170K Hold
22,135
– – ﹤0.01% 2414
2023
Q2 		$224K Buy
+22,135
New +$213K ﹤0.01% 2397

Other funds holding IMRX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Janney Montgomery Scott's IMRX Position: Q2 2024 in Review

Janney Montgomery Scott sold out of Immuneering (IMRX) in Q2 2024, closing a stake of 16,055 shares — an estimated $46K sold.

Janney Montgomery Scott first reported a position in IMRX in Q2 2023 and held it in 4 quarters. The position peaked at $224K in Q2 2023. 59 funds tracked by Wall St. Rank hold IMRX as of Q2 2024.

  • Janney Montgomery Scott reported no remaining Immuneering position as of Q2 2024 after selling out during the quarter.
  • Janney Montgomery Scott sold 16,055 Immuneering shares in Q2 2024, an estimated $46K.
  • Janney Montgomery Scott first reported a position in Immuneering in Q2 2023 and held it in 4 quarters.
  • Janney Montgomery Scott's Immuneering position peaked at $224K in Q2 2023.
  • 59 funds tracked by Wall St. Rank held Immuneering as of Q2 2024.

Based on Janney Montgomery Scott's 13F filing for Q2 2024, filed 25 Jul 2024.